These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16890803)

  • 1. The hypoxic inducible stress response as a target for cancer drug discovery.
    Welsh SJ; Koh MY; Powis G
    Semin Oncol; 2006 Aug; 33(4):486-97. PubMed ID: 16890803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition.
    Choi H; Chun YS; Kim SW; Kim MS; Park JW
    Mol Pharmacol; 2006 Nov; 70(5):1664-71. PubMed ID: 16880289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1 in human breast and prostate cancer.
    Kimbro KS; Simons JW
    Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
    Shi M; Guo XT; Shu MG; Chen FL; Li LW
    Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression.
    O'Donnell JL; Joyce MR; Shannon AM; Harmey J; Geraghty J; Bouchier-Hayes D
    Cancer Treat Rev; 2006 Oct; 32(6):407-16. PubMed ID: 16889900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes.
    Choi JH; Cho HK; Choi YH; Cheong J
    Biochem J; 2009 Nov; 424(2):285-96. PubMed ID: 19712049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
    Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
    Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effect of echinomycin on hypoxia-inducible factor-1 activity under normoxic and hypoxic conditions.
    Vlaminck B; Toffoli S; Ghislain B; Demazy C; Raes M; Michiels C
    FEBS J; 2007 Nov; 274(21):5533-42. PubMed ID: 17916190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
    Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
    Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression.
    Elser M; Borsig L; Hassa PO; Erener S; Messner S; Valovka T; Keller S; Gassmann M; Hottiger MO
    Mol Cancer Res; 2008 Feb; 6(2):282-90. PubMed ID: 18314489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
    Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
    Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
    Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
    Patiar S; Harris AL
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
    Rapisarda A; Melillo G
    Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
    Balamurugan K; Luu VD; Kaufmann MR; Hofmann VS; Boysen G; Barth S; Bordoli MR; Stiehl DP; Moch H; Schraml P; Wenger RH; Camenisch G
    Oncogene; 2009 Sep; 28(37):3274-85. PubMed ID: 19581925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of HIF-1 inhibitors as anticancer agents.
    Semenza GL
    Drug Discov Today; 2007 Oct; 12(19-20):853-9. PubMed ID: 17933687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.